Anticoagulant potential of regioselective derivatized cellulose

Biomaterials

Volumn 22, Issue 20, 2001, Pages 2719-2729

  Groth, Thomas ^a   Wagenknecht, Wolfgang ^b  

^a INSTITUTE OF MATERIALS RESEARCH   (Germany)

^b FRAUNHOFER INSTITUTE FOR APPLIED POLYMER RESEARCH   (Germany)

Author keywords

Cellulose sulfates; Clotting times; Factor Xa assay; Heparinoid activity; Regioselective derivatization; Thrombin assay

Indexed keywords

AMMONIA; CELLULOSE; PHOSPHATES; SULFUR;

ANTICOAGULANT ACTIVITIES;

BIOASSAY;

BLOOD CLOTTING FACTOR 10A; CELLULOSE DERIVATIVE; CELLULOSE PHOSPHATE; CELLULOSE SULFATE; QUATERNARY AMMONIUM DERIVATIVE; THROMBIN;

ANTICOAGULATION; ARTICLE; ASSAY; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DERIVATIZATION; DEVELOPMENT; HUMAN; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; SULFATION; THROMBIN TIME;

ANTICOAGULANTS; BLOOD COAGULATION; CELLULOSE; FACTOR XA; HEPARIN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR WEIGHT; PROTHROMBIN;

EID: 0034899195     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(01)00013-8     Document Type: Article

References (41)

1. Choosing a membrane
2. Biocompatibility of high-flux membranes
3. Complement activation during extracorporal therapy: Biochemistry, cell biology and clinical relevance
4. Anaphylactoid reactions in hemodialysis patients treated with the AN 69S dialyser
5. Long-term results: Cellulosic vs. synthetic membranes
6. Membranes for dialysis
7. Focusing on Membranes
8. Biomaterials for blood-contacting applications
9. Biocompatibility of extracorporal blood treatment. Selection of haemostatic parameters
10. Biocompatibility issues in hemodialysis
11. Complications of hemodialysis
12. Binding of heparin onto ethylene-vinyl alcohol copolymer membrane
13. In vitro evaluation of heparinized Cuprophan hemodialysis membranes
14. Thromboresistance of bulk heparinized catheters in human
15. Interactions of biospecific functional polymers with blood proteins and cells
16. Bioresorbable, heparinized polymers for stent coating: In vitro studies on heparinization efficiency, maintainance of anticoagulant properties and improvement of stent haemocompatibility
17. Heparin or heparan sulfate - What is the difference?
18. Chemically synthesized heparin-derived oligosaccharides
19. Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
20. Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced change in antithrombin III
21. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa
22. Serpins: Antithrombin and other inhibitors of coagulation and fibrinolysis. Evidence from amino acid sequences
23. Structural basis for anticoagulant activity of heparin. 1. Relationship to the number of charged groups
24. The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III
25. Synthesis of new heparinoids with high anticoagulant activity
26. Synthesis and sulfation of branched dextrans
27. Plasma recalcification as a measure of contact phase activation and heparinization efficiacy after contact with biomaterials
28. Regioselektive veresterung und veretherung von cellulosederivaten
29. Synthesis and substituent distribution of Na-cellulose sulfates via O-trimethylsilyl cellulose as intermediate
30. 4-N,N-dimethlyformamide cellulose system
31. Artificial polysaccharides and their biological activities
32. Über die blutgerinnungs-hemmende Wirkung und Speicherung von Amylose-Schwefelsäureestern
33. Role of heparin and heparinlike molcules in thrombosis and atherosclerosis
34. Protein-binding domains of heparin and other sufated glycosaminoglycans
35. Biosynthesis of heparin/heparan sulfate. The D-glucosaminyl 3-O-sulfotransferase reaction: Target and inhibitor saccharides
36. Combined NMR and molcular modelling study of an ioduronicacid-containing trisaccharide related to antithrombotic heparin fragments
37. Jozefonvicz, Randomness, biospecifity: Random copolymers are capable of biospecific molcular recognition in living systems
38. Anticoagulant and antiprotease activities of a heparinoid sulfated glucoside-bearing polymer
39. Heparin and its biocompatibility
40. Photochemical immobilization of heparin, dermatan sulfate, dextran sulfate and endothelial cell surface heparan sulfate onto cellulose membranes for the preparation of athrombogenic and antithrombogenic polymers